Ischemic heart disease in liver cirrhosis: modern realities
https://doi.org/10.26295/OS.2020.77.35.001
Abstract
Debatable data on prevalence of coronary artery disease in liver cirrhosis are presented in the review. Influence of etiology of liver cirrhosis, of other risk factors on possibility of development of coronary atherosclerosis in terminal stages of liver pathology is considered. Necessity of conducting researches for purpose of specification of frequency of development of coronary artery disease in liver cirrhosis, of its interrelation with features of hepatic pathology, of possibilities of improvement of risk stratification and working out of treatment strategy of patients, including those expecting liver transplantation is noted.
About the Authors
P. V. Koroy
ФГБОУ ВО СтГМУ Минздрава России
Россия
Россия
M. A. Vitkovskaya
ФГБОУ ВО СтГМУ Минздрава России
Россия
Россия
A. I. Raevskaya
ФГБОУ ВО СтГМУ Минздрава России
Россия
Россия
T. R. Dudov
ФГБОУ ВО СтГМУ Минздрава России
Россия
Россия
A. V. Yagoda
ФГБОУ ВО СтГМУ Минздрава России
Россия
Россия
References
1. Martin P., DiMartini A., Feng S. et al. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation // Hepatology. 2014. Vol. 59. Р. 1144-1165.
2. VanWagner L. B. A simple clinical calculator for assessing cardiac event risk in liver transplant candidates: the cardiovascular risk in orthotopic liver transplantation score // Clin. Liver Dis. (Hoboken). 2018. Vol. 11. Р. 145-148.
3. Fussner L. A., Heimbach J. K., Fan C. et al. Cardiovascular disease after liver transplantation: when, what, and who is at risk // Liver Transpl. 2015. Vol. 21. Р. 889-896.
4. Kwon H. M., Hwang G. S. Cardiovascular dysfunction and liver transplantation // Korean J. Anesthesiol. 2018. Vol. 71. Р. 85-91.
5. VanWagner L. B., Serper M., Kang R. et al. Factors associated with major adverse cardiovascular events after liver transplantation among a national sample // Am. J. Transplant. 2016. Vol. 16. Р. 2684-2694.
6. An J., Shim J. H., Kim S. O. et al. Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study // Circulation. 2014. Vol. 130. Р. 1353-1362.
7. Gologorsky E., Pretto E. A. Jr., Fukazawa K. Coronary artery disease and its risk factors in patients presenting for liver transplantation // J. Clin. Anesth. 2013. Vol. 25. Р. 618-623.
8. Howell W. L., Manion W. C. The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17,731 autopsies // Am. Heart J. 1960. Vol. 60. Р. 341-344.
9. Parikh N. S., Navi B. B., Kumar S. et al. Association between liver disease and intracranial hemorrhage // J. Stroke Cerebrovasc. Dis. 2016. Vol. 25. Р. 543-548.
10. Raval Z., Harinstein M. E., Skaro A. I. et al. Cardiovascular risk assessment of the liver transplant candidate // J. Am. Coll. Cardiol. 2011. Vol. 58. Р. 223-231.
11. Hogan B. J., Gonsalkorala E., Heneghan M. A. Evaluation of coronary artery disease in potential liver transplant recipients // Liver Transplant. 2017. Vol. 23. Р. 386-395.
12. Tsai M. C., Yang T. W., Wang C. C. et al. Favorable clinical outcome of nonalcoholic liver cirrhosis patients with coronary artery disease: a population-based study // World J. Gastroenterol. 2018. Vol. 24. Р. 3547-355.
13. Keeling A. N., Flaherty J. D., Davarpanah A. H. et al. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience // J. Cardiovasc. Med. (Hagerstown). 2011. Vol. 12. Р. 460-468.
14. Kemmer N., Case J., Chandna S. et al. The role of coronary calcium score in the risk assessment of liver transplant candidates // Transplant. Proc. 2014. Vol. 46. Р. 230-233.
15. Moon Y. J., Kwon H. M., Jung K. W. et al. Risk stratification of myocardial injury after liver transplantation in patients with computed tomographic coronary angiography-diagnosed coronary artery disease // Am. J. Transplant. 2019. Vol. 19. Р. 2053-2066.
16. Patel S. S., Nabi E., Guzman L. et al. Coronary artery disease in decompensated patients undergoing liver transplantation evaluation // Liver Transpl. 2018. Vol. 24. Р. 333-342.
17. Skaro A. I., Gallon L. G., Lyuksemburg V. et al. The impact of coronary artery disease on outcomes after liver transplantation // J. Cardiovasc. Med. (Hagerstown). 2016. Vol. 17. Р. 875-885.
18. Tiukinhoy-Laing S. D., Rossi J. S., Bayram M. et al. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation // Am. J. Cardiol. 2006. Vol. 98. Р. 178-181.
19. Patel S. S., Lin F. P., Rodriguez V. A. et al. The relationship between coronary artery disease and cardiovascular events early after liver transplantation // Liver Int. 2019. Vol. 39. Р. 1363-1371.
20. Satapathy S. K., Vanatta J. M., Helmick R. A. et al. Outcome of liver transplant recipients with revascularized coronary artery disease: a comparative analysis with and without cardiovascular risk factors // Transplantation. 2017. Vol. 101. Р. 793-803.
21. Kazankov K., Munk K., ?vrehus K. A. et al. High burden of coronary atherosclerosis in patients with cirrhosis // Eur. J. Clin. Invest. 2017. Vol. 47. Р. 565-573.
22. Wray C., Scovotti J. C., Tobis J. et al. Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study // Am. J. Transplant. 2013. Vol. 13. Р. 184-191.
23. Azarbal B., Poommipanit P., Arbit B. et al. Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver disease referred for liver transplantation // Liver Transpl. 2011. Vol. 17. Р. 809-813.
24. Yong C. M., Sharma M., Ochoa V. et al. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation // Liver Transpl. 2010. Vol. 16. Р. 1242-1248.
25. Diedrich D. A., Findlay J. Y., Harrison B. A. et al. Influence of coronary artery disease on outcomes after liver transplantation // Transplant. Proc. 2008. Vol. 40. Р. 3554-3557.
26. Snipelisky D. F., McRee C., Seeger K. et al. Coronary interventions before liver transplantation might not avert postoperative cardiovascular events // Tex. Heart Inst. J. 2015. Vol. 42. Р. 438-442.
27. Berzigotti A., Bonfiglioli A., Muscari A. et al. Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis // Liver Int. 2005. Vol. 25. Р. 331-336.
28. Kokolis S., Marmur J. D., Clark L. T. et al. Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans // J. Invasive Cardiol. 2006. Vol. 18. Р. 304-307.
29. Lisman T., Caldwell S. H., Burroughs A. K. et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs // J. Hepatol. 2010. Vol. 53. Р. 362-371.
30. Tripodi A., Mannucci P. M. The coagulopathy of chronic liver disease // N. Engl. J. Med. 2011. Vol. 365. Р. 147-156.
31. Bassani L., Fernandes S. A., Raimundo F. V. et al. Lipid profile of cirrhotic patients and its association with prognostic scores: a cross-sectional study // Arq. Gastroenterol. 2015. Vol. 52. Р. 210-215.
32. Boemeke L., Bassani L., C. Marroni A. et al. Lipid profile in cirrhotic patients and its relation to clinical outcome // Arq. Bras. Cir. Dig. 2015. Vol. 28. Р. 132-135.
33. Janicko M., Vesel?ny E., Lesko D. et al. Serum cholesterol is a significant and independent mortality predictor in liver cirrhosis patients // Ann. Hepatol. 2013. Vol. 12. Р. 581-587.
34. Mandal S. K., Sil K., Chatterjee S. et al. A study on lipid profiles in chronic liver diseases // Natl. J. Med. Res. 2013. Vol. 3. Р. 70-72.
35. Phukan J. P., Sinha A., Deka J. P. Serum lipid profile in alcoholic cirrhosis: a study in a teaching hospital of north-eastern India // Niger. Med. J. 2013. Vol. 54. Р. 5-9.
36. Suman C., Kumar B. R., Prabhakar B. Lipid profile in assessing the severity of cirrhosis // IAIM. 2016. Vol. 3. Р. 113-123.
37. McCaughan G. W., Crawford M., Sandroussi C. et al. Assessment of adult patients with chronic liver failure for liver transplantation in 2015: who and when? // Intern. Med. J. 2016. Vol. 46. Р. 404-412.
38. Kalaitzakis E., Rosengren A., Skommevik T. et al. Coronary artery disease in patients with liver cirrhosis // Dig. Dis. Sci. 2010. Vol. 55. Р. 467-475.
39. Stepanova M., Wai H., Saab S. et al. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013 // JAMA Intem. Med. 2014. Vol. 174. Р. 1407-1409.
40. Danielsen K. V., Wiese S., Hove J. et al. Pronounced coronary arteriosclerosis in cirrhosis: influence on cardiac function and survival? // Dig. Dis. Sci. 2018. Vol. 63. Р. 1355-1362.
41. Loria P., Marchesini G., Nascimbeni F. et al. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology // Atherosclerosis. 2014. Vol. 232. Р. 99-109.
42. Vanwagner L. B., Bhave M., Te H. S. et al. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events // Hepatology. 2012. Vol. 56. Р. 1741-1750.
43. Kadayifci A., Tan V., Ursell P. C. et al. Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison between NASH-related cirrhosis and cirrhosis due to other aetiologies // J. Hepatol. 2008. Vol. 49. Р. 595-599.
44. Kalaitzakis E., Bj?rnsson E. Coronary artery disease in liver cirrhosis: does the aetiology of liver disease matter? // J. Hepatol. 2009. Vol. 51. Р. 962-963.
45. Patel S., Kiefer T. L., Ahmed A. et al. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease // Am. J. Cardiol. 2011. Vol. 108. Р. 1552-1555.
46. Wang C. H., Chen C. J., Lee M. H. et al. Chronic hepatitis B infection and risk of atherosclerosis-related mortality: a 17-year follow-up study based on 22,472 residents in Taiwan // Atherosclerosis. 2010. Vol. 211. Р. 624e9.
47. Ciccone M. M., Principi M., Ierardi E. et al. Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage? // J. Cardiovasc. Med. (Hagerstown). 2015. Vol. 16. Р. 11-21.
48. Dai C. Y., Yeh M. L., Huang C. F. et al. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles // J. Gastroenterol. Hepatol. 2015. Vol. 30. Р. 879-884.
49. Negro F. Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases // J. Hepatol. 2014. Vol. 61. Р. S69-S78.
50. Ambrosino P., Lupoli R., DiMinno R. et al. The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: a systematic review and metaanalysis // Int. J. Cardiol. 2016. Vol. 221. Р. 746-754.
51. Lee K. K., Stelzle D., Bing R. et al. Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study // Lancet Gastroenterol. Hepatol. 2019. Vol. 4. Р. 794-804.
52. Olubamwo O. O., Onyeka I. N., Miettola J. et al. Hepatitis C as a risk factor for carotid atherosclerosis - a systematic review // Clin. Physiol. Funct. Imaging. 2016. Vol. 36. Р. 249-260.
53. Novo G., Macaione F., Giannitrapani L. et al. Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study // Aliment. Pharmacol. Ther. 2018. Vol. 48. Р. 740-749.
54. Roed T., Lebech A. M., Kjaer A. et al. Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature // Clin. Physiol. Funct. Imaging. 2012. Vol. 32. Р. 421-430.
55. Pothineni N. V., Rochlani Y., Vallurupalli S. et al. Comparison of angiographic burden of coronary artery disease in patients with versus without hepatitis C infection // Am. J. Cardiol. 2015. Vol. 116. Р. 1041-1044.
56. Wong R. J., Kanwal F., Younossi Z. M. et al. Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature // Dig. Dis. Sci. 2014. Vol. 59. Р. 1586-1593.
57. Badawi A., Di Giuseppe G., Arora P. Cardiovascular disease risk in patients with hepatitis C infection: results from two general population health surveys in Canada and the United States (2007-2017) // PLoS ONE. 2018. Vol. 13. Р. e0208839.
58. Nahon P., Bourcier V., Layese R. et al. Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications // Gastroenterology. 2017. Vol. 152. Р. 142-156.
59. Savji N., Rockman C. B., Skolnick A. H. et al. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects // J. Am. Coll. Cardiol. 2013. Vol. 61. Р. 1736-1743.
60. VanWagner L. B., Harinstein M. E., Runo J. R. et al. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations // Am. J. Transplant. 2018. Vol. 18. Р. 30-42.
61. Cholongitas E., Senzolo M., Patch D. et al. Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality // Eur. J. Gastroenterol. Hepatol. 2009. Vol. 21. Р. 744-750.
Review
For citations:
Koroy P.V., Vitkovskaya M.A., Raevskaya A.I., Dudov T.R., Yagoda A.V. Ischemic heart disease in liver cirrhosis: modern realities. Lechaschi Vrach. 2020;(2):6-9. (In Russ.) https://doi.org/10.26295/OS.2020.77.35.001
Views:
177
JATS XML
Email this article 
